the pharmacogenetic profiling reveals a mutation in a cyp450 enzyme that causes increased enzyme activity. which of the statements below is incorrect? - There are variations in the enzymes as a result of genetic polymorphism
- It would require that the patient with this mutation is given greater than the standard dose of a drug if it is metabolized by this enzyme
- The profiling can be used to predict drug-drug interactions
- The CYP450 variants have no influence on drug metabolism